Pulmonary microvascular blood flow in mild chronic obstructive pulmonary disease and emphysema: The MESA COPD study

American Journal of Respiratory and Critical Care Medicine

Volumn 192, Issue 5, 2015, Pages 570-580

  Hueper, Katja ^a,b   Vogel Claussen, Jens ^a,b   Parikh, Megha A ^c   Austin, John H M ^c   Bluemke, David A ^d   Carr, James ^e   Choi, Jiwoong ^f,g   Goldstein, Thomas A ^h   Gomes, Antoinette S ⁱ   Hoffman, Eric A ^f,j   Kawut, Steven M ^k   Lima, Joao ^a   Michos, Erin D ^a   Post, Wendy S ^a   Po, Ming Jack ^l   Prince, Martin R ^c   Liu, Kiang ^m   Rabinowitz, Dan ⁿ   Skrok, Jan ^a   Smith, Ben M ^c   Watson, Karol ^o   Yin, Youbing ^p   Zambeli Ljepovic, Alan M ^l   Barr, R Graham ^c   more..

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c Department of Medicine   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

^f UNIVERSITY OF IOWA   (United States)

^g UNIVERSITY OF IOWA   (United States)

^h STANFORD UNIVERSITY   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j University of Iowa   (United States)

^k UNIVERSITY OF PENNSYLVANIA   (United States)

^l Department of Earth and Environmental Sciences   (United States)

^m NORTHWESTERN UNIVERSITY   (United States)

ⁿ NONE   (United States)

^o UNIVERSITY OF CALIFORNIA   (United States)

^p VIDA Diagnostics Inc   (United States)

more..

Author keywords

Chronic obstructive pulmonary disease (COPD); Gadolinium enhanced MRI; Lung emphysema; Pulmonary microvascular blood flow (PMBF); Small airway disease

Indexed keywords

GLUCOSE; HEMOGLOBIN; PENTETIC ACID; GADOLINIUM;

ADULT; AGED; ARTICLE; BODY HEIGHT; BODY WEIGHT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE FUNCTION; HEART OUTPUT; HEMOGLOBIN BLOOD LEVEL; HOME OXYGEN THERAPY; HUMAN; LEUKOCYTE COUNT; LUNG BLOOD FLOW; LUNG BLOOD VOLUME; LUNG EMPHYSEMA; LUNG PERFUSION; MAJOR CLINICAL STUDY; MALE; MEAN TRANSIT TIME; MICROCIRCULATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSTRUCTIVE AIRWAY DISEASE; OXYGEN SATURATION; OXYGENATION; PANLOBULAR EMPHYSEMA; PARASEPTAL EMPHYSEMA; PLETHYSMOGRAPHY; PRIORITY JOURNAL; PULMONARY MICROVASCULAR BLOOD FLOW; RADIOLOGIST; RESIDUAL VOLUME; SLEEP DISORDERED BREATHING; SMALL AIRWAY DISEASE; SMOKING; SPIROMETRY; SYSTOLIC BLOOD PRESSURE; TOTAL LUNG CAPACITY; CASE CONTROL STUDY; COHORT ANALYSIS; LUNG; LUNG CIRCULATION; MICROVASCULATURE; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; RADIOGRAPHY; SCINTIGRAPHY; SEVERITY OF ILLNESS INDEX; VASCULARIZATION;

AGED; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GADOLINIUM; HUMANS; LUNG; MAGNETIC RESONANCE IMAGING; MALE; MICROVESSELS; MIDDLE AGED; PERFUSION IMAGING; PROSPECTIVE STUDIES; PULMONARY CIRCULATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; SEVERITY OF ILLNESS INDEX; SMOKING; SPIROMETRY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84942288223     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201411-2120OC     Document Type: Article

References (69)

1. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2095-2128.
2. Minino AM, Murphy SL. Death in the United States, 2010. NCHS Data Brief 2012;99:1-8.
3. Tuder RM, Petrache I. Pathogenesis of chronic obstructive pulmonary disease. J Clin Invest 2012;122:2749-2755.
4. Leone A, Landini L. Vascular pathology from smoking: look at the microcirculation! Curr Vasc Pharmacol 2013;11:524-530.
5. Vejakama P, Thakkinstian A, Lertrattananon D, Ingsathit A, Ngarmukos C, Attia J. Reno-protective effects of renin-angiotensin system blockade in type 2 diabetic patients: a systematic review and network meta-analysis. Diabetologia 2012;55:566-578.
6. Rahman MM, Laher I. Structural and functional alteration of blood vessels caused by cigarette smoking: an overview of molecular mechanisms. Curr Vasc Pharmacol 2007;5:276-292.
7. Ferrer E, Peinado VI, Castañeda J, Prieto-Lloret J, Olea E, González-Martín MC, Vega-Agapito MV, Díez M, Domínguez-Fandos D, Obeso A, et al. Effects of cigarette smoke and hypoxia on pulmonary circulation in the guinea pig. Eur Respir J 2011;38:617-627.
8. Hoffman D, Hecht S. Advances in tobacco carcinogenesis. In: Cooper CS, Grover PL, editors. Chemical carcinogenesis and mutagenesis I. Handbook of experimental pharmacology. Vol. 94, No. I. Heidelberg: Springer; 1990. pp. 63-102.
9. Nana-Sinkam SP, Lee JD, Sotto-Santiago S, Stearman RS, Keith RL, Choudhury Q, Cool C, Parr J, Moore MD, Bull TM, et al. Prostacyclin prevents pulmonary endothelial cell apoptosis induced by cigarette smoke. Am J Respir Crit Care Med 2007;175:676-685.
10. Petrache I, Natarajan V, Zhen L, Medler TR, Richter AT, Cho C, Hubbard WC, Berdyshev EV, Tuder RM. Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice. Nat Med 2005;11:491-498.
11. Liebow AA. Pulmonary emphysema with special reference to vascular changes. Am Rev Respir Dis 1959;80:67-93.
12. Santos S, Peinado VI, Ramírez J, Melgosa T, Roca J, Rodriguez-Roisin R, Barberà JA. Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD. Eur Respir J 2002;19: 632-638.
13. Peinado VI, Barbera JA, Ramirez J, Gomez FP, Roca J, Jover L, Gimferrer JM, Rodriguez-Roisin R. Endothelial dysfunction in pulmonary arteries of patients with mild COPD. Am J Physiol 1998; 274:L908-L913.
14. Hatabu H, Tadamura E, Levin DL, Chen Q, Li W, Kim D, Prasad PV, Edelman RR. Quantitative assessment of pulmonary perfusion with dynamic contrast-enhanced MRI. Magn ResonMed 1999;42:1033-1038.
15. Alford SK, van Beek EJ, McLennan G, Hoffman EA. Heterogeneity of pulmonary perfusion as a mechanistic image-based phenotype in emphysema susceptible smokers. Proc Natl Acad Sci USA 2010; 107:7485-7490.
16. Ohno Y, Hatabu H, Murase K, Higashino T, Kawamitsu H, Watanabe H, Takenaka D, Fujii M, Sugimura K. Quantitative assessment of regional pulmonary perfusion in the entire lung using threedimensional ultrafast dynamic contrast-enhanced magnetic resonance imaging: preliminary experience in 40 subjects. J Magn Reson Imaging 2004;20:353-365.
17. Jang YM, Oh YM, Seo JB, Kim N, Chae EJ, Lee YK, Lee SD. Quantitatively assessed dynamic contrast-enhanced magnetic resonance imaging in patients with chronic obstructive pulmonary disease: correlation of perfusion parameters with pulmonary function test and quantitative computed tomography. Invest Radiol 2008;43: 403-410.
18. Estépar RS, Kinney GL, Black-Shinn JL, Bowler RP, Kindlmann GL, Ross JC, Kikinis R, Han MK, Come CE, Diaz AA, et al.; COPDGene Study. Computed tomographic measures of pulmonary vascular morphology in smokers and their clinical implications. Am J Respir Crit Care Med 2013;188:231-239.
19. Fan L, Xia Y, Guan Y, Yu H, Zhang TF, Liu SY, Li B. Capability of differentiating smokers with normal pulmonary function from COPD patients: a comparison of CT pulmonary volume analysis and MR perfusion imaging. Eur Radiol 2013;23:1234-1241.
20. Fan L, Xia Y, Guan Y, Zhang TF, Liu SY. Characteristic features of pulmonary function test, CT volume analysis and MR perfusion imaging in COPD patients with different HRCT phenotypes. Clin Respir J 2014;8:45-54.
21. Xia Y, Guan Y, Fan L, Liu SY, Yu H, Zhao LM, Li B. Dynamic contrast enhanced magnetic resonance perfusion imaging in high-risk smokers and smoking-related COPD: correlations with pulmonary function tests and quantitative computed tomography. COPD 2014; 11:510-520.
22. Hueper K, Vogel-Claussen J, Parikh M, Austin J, Bluemke D, Carr J, Goldstein T, Gomes A, Hoffman E, Lima J, et al. Veränderungen der lungenperfusion bei patienten mit chronisch obstruktiver Lungenerkrankung (COPD): die MESA COPD Studie [abstract]. Fortschr Röntgenstr 2012;184(S 01):VO318-1.
23. Hueper K, Vogel-Claussen J, Parikh M, Austin J, Bluemke D, Carr J, Goldstein TA, Gomes AS, Hoffman EA, Lima JAC, et al. Pulmonary parenchymal blood flow in early chronic obstructive pulmonary disease (COPD): the MESA COPD Study [abstract]. Proc Intl Soc Mag Reson Med 2012;0624.
24. Hueper K, Vogel-Claussen J, Parikh M, Austin J, Bluemke DA, Carr J, Goldstein T, Gomes A, Hoffman EA, Lima J, et al. Pulmonary parenchymal perfusion in early chronic obstructive pulmonary disease (COPD): the MESA COPD Study [abstract]. Am J Respir Crit Care Med 2012;185:A4345.
25. Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR, Greenland P, Jacob DR Jr, Kronmal R, Liu K, et al. Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 2002;156: 871-881.
26. Barr RG, Mesia-Vela S, Austin JH, Basner RC, Keller BM, Reeves AP, Shimbo D, Stevenson L. Impaired flow-mediated dilation is associated with low pulmonary function and emphysema in ex-smokers: the Emphysema and Cancer Action Project (EMCAP) Study. Am J Respir Crit Care Med 2007;176:1200-1207.
27. Rodriguez J, Jiang R, Johnson WC, MacKenzie BA, Smith LJ, Barr RG. The association of pipe and cigar use with cotinine levels, lung function, and airflow obstruction: a cross-sectional study. Ann Intern Med 2010;152:201-210.
28. Hueper K, Parikh MA, Prince MR, Schoenfeld C, Liu C, Bluemke DA, Dashnaw SM, Goldstein TA, Hoffman EA, Lima JA, et al. Quantitative and semiquantitative measures of regional pulmonary microvascular perfusion by magnetic resonance imaging and their relationships to global lung perfusion and lung diffusing capacity: the multiethnic study of atherosclerosis chronic obstructive pulmonary disease study. Invest Radiol 2013;48:223-230.
29. Huang W, Yen RT, McLaurine M, Bledsoe G. Morphometry of the human pulmonary vasculature. J Appl Physiol (1985) 1996;81: 2123-2133.
30. Weibel ER. A quantitative approach to the morphologic study of the peripheral pulmonary vasculature. Med Thorac 1962;19:208-214.
31. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, et al.; ATS/ ERS Task Force. Standardisation of spirometry. Eur Respir J 2005; 26:319-338.
32. Hankinson JL, Kawut SM, Shahar E, Smith LJ, Stukovsky KH, Barr RG. Performance of American Thoracic Society-recommended spirometry reference values in a multiethnic sample of adults: the Multi-Ethnic Study of Atherosclerosis (MESA) lung study. Chest 2010;137:138-145.
33. Celli BR, MacNee W; ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004;23:932-946.
34. Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187:347-365.
35. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999;159:179-187.
36. Sieren JP, Hoffman EA, Baumhauer H, Barr RG, Goldin JG, Rennard S. CT Imaging Protocol Standardization for use in a Multicenter Study: SPIROMICS. Chicago, IL: Radiological Society of North America; 2011.
37. Gevenois PA, de Maertelaer V, De Vuyst P, Zanen J, Yernault JC. Comparison of computed density and macroscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med 1995;152: 653-657.
38. Hoffman EA, Ahmed FS, Baumhauer H, Budoff M, Carr JJ, Kronmal R, Reddy S, Barr RG. Variation in the percent of emphysema-like lung in a healthy, nonsmoking multiethnic sample. The MESA lung study. Ann Am Thorac Soc 2014;11:898-907.
39. Smith BM, Austin JHM, Newell JD Jr, D'Asousa BM, Rozenshtein A, Hoffman EA, Ahmed F, Barr RG. Pulmonary emphysema subtypes on computed tomography: the MESA COPD Study. Am J Med 2014; 127:94, e7-e23.
40. Macintyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005;26:720-735.
41. Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, Casaburi R, Crapo R, Enright P, van der Grinten CP, et al. Standardisation of the measurement of lung volumes. Eur Respir J 2005;26:511-522.
42. MESA. Field center procedures manual of operations: Multi-Ethnic Study of Atherosclerosis [accessed 2012 Jun 1]. Available from: http://www.mesa-nhlbi.org/PublicDocs/2011/MESAE5-MOPJanuary2011.pdf
43. Young AA, Cowan BR, Thrupp SF, Hedley WJ, Dell'Italia LJ. Left ventricular mass and volume: fast calculation with guide-point modeling on MR images. Radiology 2000;216:597-602.
44. Kawut SM, Poor HD, Parikh MA, Hueper K, Smith BM, Bluemke DA, Lima JA, Prince MR, Hoffman EA, Austin JH, et al. Cor pulmonale parvus in chronic obstructive pulmonary disease and emphysema: the MESA COPD study. J Am Coll Cardiol 2014;64: 2000-2009.
45. Smith BM, Kawut SM, Bluemke DA, Basner RC, Gomes AS, Hoffman E, Kalhan R, Lima JA, Liu CY, Michos ED, et al. Pulmonary hyperinflation and left ventricular mass: the Multi-Ethnic Study of Atherosclerosis COPD Study. Circulation 2013;127:1503-1511, 1511e1-6.
46. Rodríguez-Roisin R, Drakulovic M, Rodríguez DA, Roca J, Barberà JA, Wagner PD. Ventilation-perfusion imbalance and chronic obstructive pulmonary disease staging severity. J Appl Physiol (1985) 2009;106: 1902-1908.
47. Suga K, Kawakami Y, Iwanaga H, Hayashi N, Seto A, Matsunaga N. Assessment of anatomic relation between pulmonary perfusion and morphology in pulmonary emphysema with breath-hold SPECT-CT fusion images. Ann Nucl Med 2008;22:339-347.
48. Jögi J, Ekberg M, Jonson B, Bozovic G, Bajc M. Ventilation/perfusion SPECT in chronic obstructive pulmonary disease: an evaluation by reference to symptoms, spirometric lung function and emphysema, as assessed with HRCT. Eur J Nucl MedMol Imaging 2011;38:1344-1352.
49. Pansini V, Remy-Jardin M, Faivre J-B, Schmidt B, Dejardin-Bothelo A, Perez T, Delannoy V, Duhamel A, Remy J. Assessment of lobar perfusion in smokers according to the presence and severity of emphysema: preliminary experience with dual-energy CT angiography. Eur Radiol 2009;19:2834-2843.
50. Talukder MA, Johnson WM, Varadharaj S, Lian J, Kearns PN, El-Mahdy MA, Liu X, Zweier JL. Chronic cigarette smoking causes hypertension, increased oxidative stress, impaired NO bioavailability, endothelial dysfunction, and cardiac remodeling in mice. Am J Physiol Heart Circ Physiol 2011;300: H388-H396.
51. Green LA, Petrusca D, Rajashekhar G, Gianaris T, Schweitzer KS, Wang L, Justice MJ, Petrache I, Clauss M. Cigarette smoke-induced CXCR3 receptor up-regulation mediates endothelial apoptosis. Am J Respir Cell Mol Biol 2012;47:807-814.
52. Barberà JA, Peinado VI, Santos S, Ramirez J, Roca J, Rodriguez-Roisin R. Reduced expression of endothelial nitric oxide synthase in pulmonary arteries of smokers. Am J Respir Crit Care Med 2001;164: 709-713.
53. Moro L, Pedone C, Scarlata S, Malafarina V, Fimognari F, Antonelli-Incalzi R. Endothelial dysfunction in chronic obstructive pulmonary disease. Angiology 2008;59:357-364.
54. Gordon C, Gudi K, Krause A, Sackrowitz R, Harvey BG, Strulovici-Barel Y, Mezey JG, Crystal RG. Circulating endothelial microparticles as a measure of early lung destruction in cigarette smokers. Am J Respir Crit Care Med 2011;184:224-232.
55. Takahashi T, Kobayashi S, Fujino N, Suzuki T, Ota C, He M, Yamada M, Suzuki S, Yanai M, Kurosawa S, et al. Increased circulating endothelial microparticles in COPD patients: a potential biomarker for COPD exacerbation susceptibility. Thorax 2012;67:1067-1074.
56. Thomashow MA, Shimbo D, Parikh MA, Hoffman EA, Vogel-Claussen J, Hueper K, Fu J, Liu CY, Bluemke DA, Ventetuolo CE, et al. Endothelial microparticles in mild chronic obstructive pulmonary disease and emphysema: the Multi-Ethnic Study of Atherosclerosis Chronic Obstructive Pulmonary Disease study. Am J Respir Crit Care Med 2013;188:60-68.
57. Hayes JA, Korthy A, Snider GL. The pathology of elastase-induced panacinar emphysema in hamsters. J Pathol 1975;117:1-14.
58. Petrache I, Fijalkowska I, Zhen L, Medler TR, Brown E, Cruz P, Choe KH, Taraseviciene-Stewart L, Scerbavicius R, Shapiro L, et al. A novel antiapoptotic role for a1-antitrypsin in the prevention of pulmonary emphysema. Am J Respir Crit Care Med 2006;173:1222-1228.
59. Schmid ST, Koepke J, Dresel M, Hattesohl A, Frenzel E, Perez J, Lomas DA, Miranda E, Greulich T, Noeske S, et al. The effects of weekly augmentation therapy in patients with PiZZ a1-antitrypsin deficiency. Int J Chron Obstruct Pulmon Dis 2012; 7:687-696.
60. 1-Antitrypsin modulates lung endothelial cell inflammatory responses to TNF-a. Am J Respir Cell Mol Biol 2013; 49:143-150.
61. Polosukhin VV, Lawson WE, Milstone AP, Egunova SM, Kulipanov AG, Tchuvakin SG, Massion PP, Blackwell TS. Association of progressive structural changes in the bronchial epithelium with subepithelial fibrous remodeling: a potential role for hypoxia. Virchows Arch 2007;451:793-803.
62. Barr RG, Bluemke DA, Ahmed FS, Carr JJ, Enright PL, Hoffman EA, Jiang R, Kawut SM, Kronmal RA, Lima JA, et al. Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med 2010;362:217-227.
63. Chaouat A, Weitzenblum E, Krieger J, Ifoundza T, Oswald M, Kessler R. Association of chronic obstructive pulmonary disease and sleep apnea syndrome. Am J Respir Crit Care Med 1995;151: 82-86.
64. Sanders MH, Newman AB, Haggerty CL, Redline S, Lebowitz M, Samet J, O'Connor GT, Punjabi NM, Shahar E; Sleep Heart Health Study. Sleep and sleep-disordered breathing in adults with predominantly mild obstructive airway disease. Am J Respir Crit Care Med 2003; 167:7-14.
65. Panting JR, Gatehouse PD, Yang GZ, Grothues F, Firmin DN, Collins P, Pennell DJ. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med 2002;346:1948-1953.
66. Wang L, Jerosch-Herold M, Jacobs DR Jr, Shahar E, Folsom AR. Coronary risk factors and myocardial perfusion in asymptomatic adults: the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol 2006;47:565-572.
67. Drummond MB, Hansel NN, Connett JE, Scanlon PD, Tashkin DP, Wise RA. Spirometric predictors of lung function decline and mortality in early chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012;185:1301-1306.
68. Seimetz M, Parajuli N, Pichl A, Veit F, Kwapiszewska G, Weisel FC, Milger K, Egemnazarov B, Turowska A, Fuchs B, et al. Inducible NOS inhibition reverses tobacco-smoke-induced emphysema and pulmonary hypertension in mice. Cell 2011; 147:293-305.
69. Weissmann N, Lobo B, Pichl A, Parajuli N, Seimetz M, Puig-Pey R, Ferrer E, Peinado VI, Domínguez-Fandos D, Fysikopoulos A, et al. Stimulation of soluble guanylate cyclase prevents cigarette smokeinduced pulmonary hypertension and emphysema. Am J Respir Crit Care Med 2014;189:1359-1373.